risks described in this report and in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, could also materially adversely affect our business, financial condition or future result
s.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information with respect to purchases of common stock of the Company made during the three months ended March 28, 2025 by the Company or any “affiliated purchaser” of the Company as defined in Rule 10b-18(a)(3) under the Exchange Act:
1
The total number of shares purchased includes: (1) shares purchased, if any, pursuant to the 2019 Plan described in footnote 2 below and (2) shares surrendered, if any, to the Company to pay the exercise price and/or to satisfy tax withholding obligations in connection with so-called stock swap exercises of employee stock options and/or the vesting of restricted stock issued to employees.
2
In February 2019, the Company publicly announced that our Board of Directors had authorized a plan (“2019 Plan”) for the Company to purchase up to 150 million shares of our common stock. This column discloses the number of shares purchased, if any, pursuant to the 2019 Plan during the indicated time periods (including shares purchased pursuant to the terms of preset trading plans meeting the requirements of Rule 10b5-1 under the Exchange Act).
Item 5. Other Information
During the fiscal quarter ended March 28, 2025, none of our Directors or officers (as defined in Rule 16a-1(f) under the Exchange Act)
adopted
or
terminated
a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, except as follows:
Bruno Pietracci
,
President, Latin America operating unit
,
adopted
a Rule 10b5-1 trading arrangement on
March 5, 2025
for the potential exercise of vested stock options and the associated sale of up to
75,727
shares of common stock of the Company, subject to certain conditions. The arrangement’s expiration date is March 5, 2027, or such earlier date upon which all transactions are completed.
James Quincey
,
Chairman of the Board of Directors and Chief Executive Officer
,
adopted
a Rule 10b5-1 trading arrangement on
February 28, 2025
for the potential exercise of vested stock options and the associated sale of up to
604,227
shares of common stock of the Company, subject to certain conditions. The arrangement’s expiration date is February 8, 2027, or such earlier date upon which all transactions are completed.
These trading plans were adopted during an open trading window.
Item 6. Exhibits
In reviewing the agreements included as exhibits to this report, please remember they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about the Company or the other parties to the